Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Seems the early run has ended... should settle down now. .022'ish.
Wow... no one wants to sell. Smart.
There are no big blocks on the Ask side, looking at Level II. Bodes well.
I hear you. For the record, I believe that this symbol has as much potential as ANY other symbol in the market, in regards to the potential value down the road compared to current value. BIEI has multiple patent applications, yet the tech that has me STOKED are the anti-aging/anti-disease(including cancer) ones. Lasers that kill diseases in the blood? Kills anti-aging bodies? Some may feel this symbol is a long-shot, but what they are really working on, were it to pay off, would be an incredible windfall for those of us buying in sub-penny. Seriously... I'm in for the long term.
Agreed... get in now. I said I wanted to wait earlier... boy, was I wrong.
Yes. Short-term, .25 minimum. The news hasn't hit elsewhere yet... should soon.
I misread initially. WOW! If this goes through, it would be big news for PURA. "Accordingly, any assets, operations and business development initiatives not earmarked for consideration within the unsolicited bid, will be directed toward Puration for ongoing management and development. Among other assets, operations and developments, the cannabis cultivation operation acquisition initiatives in California and Canada previously announced as a joint effort by both North American Cannabis Holdings and Puration are not included in the unsolicited bid to acquire North American Cannabis Holdings. Both the California and Canadian acquisition initiatives continue to develop, and in the event an acquisition of North American Cannabis Holdings proceeds, Puration will continue with the California and Canadian acquisition initiatives on its own."
So, as you surmised, PURA would be getting the California and Canadian cultivation ops, increasing the value of the company and therefore, our stock price.
The more I think about this acquisition, the more I believe you're right. This could be very good for PURA.
Link here: https://www.morningstar.com/news/access-wire/ASW_Accesswire_495666MSN/north-american-cannabis-holdings-takes-next-step-in-reaction-to-recent-acquisition-proposal.html
Whatever is not acquired in the USMJ sale, would not neccessarily be something good for PURA. Maybe/maybe not. Hard to know at this time how it would affect PURA.
Probably, yes. I'm looking at .22'ish. Not a lot of action thus far.
One buyer pushing at .236 with 72,300 shares.
Can anyone tell me whether the Level II of InvestorsHub shows PURA? I ask because OTCMarkets does not.
I've read that 8K numerous times, and, as usual, can't understand what it really says. Posters have replied that it essentially means the price shouldn't dip below .0030, because of the details therein.
I wish that companies were required to submit forms to the SEC that can be more easily understood by the layman... you know... an 8k for Dummies. LOL!
As I mentioned late last week... there is one big buyer that sets up about .0015 below whatever the ask is. So, whenever the Ask drops, he (or she or they for that matter LOL) drops the bid. Be careful, this could fall back to .02 or lower very quickly. That's my take anyway.
There's one buyer pushing it. Potential trap.
I see it falling back to .022 or at worse .02... at least today. It could fall further to where it's been at .0180, but will eventually get back up.
Yeah... a lot of day-traders are taking profits... likely to fall back to about .022 or maybe even to .02. Hard to say.
Could fall back to .02 or so, though it may hold here... hard to say.
Agreed. As I pointed out, once it breaks .02 it can run. It's not easy to know where it could run today, though I suspect .03 would be a resistance level. So, today may run as much or more than yesterday. At the very least I hope it establishes the .022-.023 area for awhile, and then runs up thereafter. Either way, it should absolutely see .03-.05 at some point in the next few months.
Very good! Trades filling at .0218 :)
It's been pushing .02, and once it breaks over that, this should return to it's former levels at .025-.04.
As has been discussed by reasonable folks here, do your own due diligence and figure out what you believe the value should be and what it could be.
In my own view, I see issues that have me concerned, but I also see incredible upside, especially regarding their anti-aging and anti-cancer (and other diseases) tech/patent applications. I think of this symbol as a low risk/high reward symbol, as I have a bit under 1k invested, yet potentially a MAJOR payoff down the line. I like my odds.
Some strong buys around .30 yesterday. .35 + today, maybe.
Exactly... ignore the manipulation, and keep your shares. I'm in with over 25% of my portfolio at .225, and feel that's a ridiculously good value.
It's easy for a virtual stranger to come in and seem like I'm cherry-coating things, but I have a lot of faith that this symbol will not only hit .40 this year, but will return in the next year or so to $1-$2. There are WAY too many good things ongoing.
New PR: CNBX Receives Positive Results From Preclinical Study on Antitumor Effects of Cannabinoids
Published: Mar 29, 2018 8:00 a.m. ET
TEL AVIV, Israel and BETHESDA, Maryland, March 29, 2018 /PRNewswire via COMTEX/ -- TEL AVIV, Israel and BETHESDA, Maryland, March 29, 2018 /PRNewswire/ --
Cannabics Pharmaceuticals Inc. (CNBX), a leader in cannabinoid diagnostic tests for personalized cancer therapy, today announced encouraging results from a preclinical study on the antitumor effects of cannabinoids on cancerous tumor cells.
The study indicates that cancer cells derived from patient blood samples are differentially sensitive to the main active compounds in cannabis, tetrahydrocannabinol (THC) and tetrahydrocannabinolic acid (THCA). Circulating tumor cells - cancer cells that detach from a primary tumor and circulate through the bloodstream - were isolated from blood samples of breast cancer and prostate cancer patients and treated with either THC or THCA. Cell viability was monitored over time.
The results indicate that the cannabinoid compounds have different apoptotic - or cell-killing effects - depending on the dosage, type of cancer and the compound configuration.
Dr. Eyal Ballan, Cannabics co-founder and chief technology officer, said "The results of this latest study further validate Cannabics' ability to perform cannabinoid sensitivity tests on liquid biopsies and indicate in vitro antitumor activity of these compounds, which should be further examined in clinical studies. While the current use of medical cannabis is largely used for palliative purposes when it comes to cancer, we are seeing a growing number of clinical studies on the antitumor effects of cannabinoids and predict we will start to see eventual FDA approvals of cannabinoids to treat various types of cancer. Our goal is to support the personalization of these treatments with our drug sensitivity and therapy monitoring tests."
https://www.marketwatch.com/story/cannabics-pharmaceuticals-receives-positive-results-from-preclinical-study-on-antitumor-effects-of-cannabinoids-2018-03-29
.... See link for more....
The things that have me the most excited for $BIEI are the disease-killing laser treatment and anti-aging patents. This symbol could eventually be bought out and long term could be worth an ungodly amount for shareholders. This is one of those symbols that one day runs up over 1,000%. There are a lot of IF's beforehand, but it has that kind of potential.
Not breaking .02 has me thinking it may dip down as low as .015. It will, in time shoot way back up, however. Solid long term outlook.
$MCOA should see .035-.04 very soon, since it is 'roughly' the appropriate level of the symbol. In time longs will be very happy to just hold it, as it will be worth a great deal more than it's current value. Reasonably this will hit .06 sometime in the next year.
To be transparent, I'm in (obviously) but I'm not pumping... just stating how I see it.
That's very positive information. .004+ soon. Thank you kindly for such a detailed explanation.
He'll be back up at .0033-.0034 tomorrow, and jump whenever he feels he needs to. Day-trader tricks. Long-termers don't play that.
See, this is where confusion sets in. I have you saying dilution IS coming, whereas another poster says it's not so. Which is it? Can anyone make sense of the polar opposite views?
Very good then. :) My apologies if I misunderstood. I don't have enough understanding of how these things read. Thanks for your input.
This is the confusing 8-k from March 5th... any help in understanding what this means would be GREATLY appreciated.
Form 8-K
On March 1, 2018, we entered into a Securities Purchase Agreement (the “ Purchase Agreement ”) by and between the Company and each of RedDiamond Partners LLC and SEG-RedaShex, LLC (each a “ Purchaser ” and collectively, the “ Purchasers ”) to sell Convertible Promissory Notes (each a “ Note ” and collectively, the “ Notes ”). Pursuant to the Purchase Agreement, the Purchasers will pay an aggregate of $300,000 for the Notes in three tranches or closings.
The Purchasers purchased Notes at the signing of the Purchase Agreement for an aggregate amount of $60,000. The Purchasers will buy additional Notes for an aggregate of $60,000 within five trading days of our filing a registration statement to cover the Purchasers’ shares of common stock issuable upon conversion of the Notes. Within five trading days of the registration statement being declared effective, the Purchasers will buy additional Notes for an aggregate of $180,000.
The Notes have a maturity date of May 31, 2018. The Notes are convertible into our common stock at a conversion price equal to 60% of the lowest traded price of our common stock in the fifteen (15) trading days prior to the conversion date. A Note can be prepaid by us at any time upon ten (10) days written notice to the Purchaser for a cash amount equal to the sum of the then outstanding principal amount of the note and interest multiplied by 130%.
The Notes limit each Purchaser to beneficial ownership of our common stock of no more than 4.99%. The Purchasers also have certain anti-dilution rights in the Purchase Agreement for a period of 12 months. These rights allow the Purchasers to exchange their Notes for any securities sold on the same terms and conditions of a subsequent financing.
Registration Rights Agreement
On March 1, 2018, we entered into a Registration Rights Agreement with the Purchasers in connection with the Purchase Agreement. In the Registration Rights Agreement, we agreed to prepare and file a registration statement with the Securities and Exchange Commission covering the resale of all of the shares of common stock issuable upon conversion of the Notes. We agreed to file an initial registration statement within 30 days of the date of the Purchase Agreement, have the registration statement declared effective no later than 90 days after its filing and keep it continuously effective until the securities are sold or may be sold under Rule 144 of the Securities Act without volume or manner-of-sale restrictions. If all of the securities cannot be registered on one registration statement, we agreed to file subsequent registration statements to register the remaining securities as promptly as allowed.
Section 3 – Securities and Trading Markets
Item 3.02 Unregistered Sale of Equity Securities
The disclosure under item 1.01 above is incorporated herein by reference. The sale of the Notes and the shares of common stock issuable upon conversion of the Notes was a private transaction exempt from registration under Section 4(a)(2) of the Securities Act of 1933, as amended. No general solicitation was made either by the Company or any person acting on its behalf, and the investor is an accredited, sophisticated investor.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Premier Biomedical, Inc.
Dated: March 5, 2018
/s/ William Hartman
By:
William Hartman
Its:
Chief Executive Officer
3
Has the 40% dilution occurred yet?
Should hit .03's this week, with so many positive developments.
PURA seems on the verge of shooting back up where it belongs. Not pumping it... just calling it as I see it. Once it breaks .02... look out.
With very positive developments in both Canadian and US legislation at the end of last week, I expect a nice uptick both short-term and, naturally, long-term.
That's BIG news for these Canadian weed stocks. Here's another article from the Toronto Star: https://www.thestar.com/news/canada/2018/03/22/liberals-plan-to-legalize-marijuana-by-mid-summer-passes-its-first-hurdle-in-the-senate.html
Big news out of Canada! From the Toronto Star...
"Liberals’ plan to legalize marijuana by midsummer passes first hurdle in the Senate
In a 44-29 vote, the Senate nudged forward Bill C-45, one of two key bills that would enact a new legal framework for cannabis production and distribution."
https://www.thestar.com/news/canada/2018/03/22/liberals-plan-to-legalize-marijuana-by-mid-summer-passes-its-first-hurdle-in-the-senate.html